Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to I-MIBG SPECT/CT

Kroiss, Alexander; Shulkin, Barry; Uprimny, Christian; Frech, Andreas; Gasser, Rudolf; Url, Christoph; Gautsch, Kurt; Madleitner, Ruth; Nilica, Bernhard; Sprinzl, Georg; Gastl, Guenther; Fraedrich, Gustav; Virgolini, Irene
January 2015
European Journal of Nuclear Medicine & Molecular Imaging;Jan2015, Vol. 42 Issue 1, p33
Academic Journal
Purpose: The aim of this study was to compare the accuracy of I-MIBG SPECT/CT with that of Ga-DOTATOC PET/CT for staging extraadrenal paragangliomas (PGL) using both functional and anatomical images (i.e. combined cross-sectional imaging) as the reference standards. Methods: The study included three men and seven women (age range 26 to 73 years) with anatomical and/or histologically proven disease. Three patients had either metastatic head and neck PGL (HNPGL) or multifocal extraadrenal PGL, and seven patients had nonmetastatic extraadrenal disease. Comparative evaluation included morphological imaging with CT, functional imaging with Ga-DOTATOC PET, and I-MIBG imaging. The imaging results were analysed on a per-patient and on a per-lesion basis. Results: On a per-patient basis, the detection rate of Ga-DOTATOC PET was 100 %, whereas that of planar I-MIBG imaging was 10.0 % and with SPECT/CT 20.0 % for both nonmetastatic and metastatic/multifocal extraadrenal PGL. On a per-lesion basis, the overall sensitivity of Ga-DOTATOC PET was 100 % (McNemar p < 0.5), that of planar I-MIBG imaging was 3.4 % (McNemar p < 0.001) and that of SPECT/CT was 6.9 % (McNemar p < 0.001). Both Ga-DOTATOC PET and anatomical imaging identified 27 lesions. Planar I-MIBG imaging identified only one lesion, and SPECT/CT two lesions. Two additional lesions were detected by Ga-DOTATOC PET but not by either I-MIBG or CT imaging. Conclusion: Our analysis in this patient cohort indicated that Ga-DOTATOC PET/CT is superior to I-MIBG SPECT/CT, particularly in head and neck and bone lesions, and provides valuable information for staging extraadrenal PGL, particularly in patients with surgically inoperable tumours or multifocal/malignant disease.


Related Articles

  • EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Taïeb, David; Timmers, Henri; Hindié, Elif; Guillet, Benjamin; Neumann, Hartmut; Walz, Martin; Opocher, Giuseppe; Herder, Wouter; Boedeker, Carsten; Krijger, Ronald; Chiti, Arturo; Al-Nahhas, Adil; Pacak, Karel; Rubello, Domenico // European Journal of Nuclear Medicine & Molecular Imaging;Dec2012, Vol. 39 Issue 12, p1977 

    Purpose: Radionuclide imaging of phaeochromocytomas (PCCs) and paragangliomas (PGLs) involves various functional imaging techniques and approaches for accurate diagnosis, staging and tumour characterization. The purpose of the present guidelines is to assist nuclear medicine practitioners in...

  • Improved Benefit of SPECT/CT Compared to SPECT Alone for the Accurate Localization of Endocrine and Neuroendocrine Tumors. Bural, Gonca G.; Muthukrishnan, Ashok; Oborski, Matthew J.; Mountz, James M. // Molecular Imaging & Radionuclide Therapy;Oct2012, Vol. 21 Issue 3, p91 

    Objective: To assess the clinical utility of SPECT/ CT in subjects with endocrine and neuroendocrine tumors compared to SPECT alone. Material and Methods: 48 subjects (31 women;17 men; mean age 54�11) with clinical suspicion or diagnosis of endocrine and neuroendocrine tumor had 50 SPECT/CT...

  • Case Report of Tc-99m Sulfur Colloid Single-Photon Emission Computed Tomography/Computed Tomography Study Differentiating Tumor from Accessory Spleen. Aggarwal, Reena; Wagner, Thomas; Navalkissoor, Shaunak // World Journal of Nuclear Medicine;Sep2013, Vol. 12 Issue 3, p129 

    We present a case report where Tc-99m sulfur colloid single-photon emission computed tomography (SPECT)/computed tomography (CT) scan was useful in characterizing a soft tissue abdominal mass and helped with patient management. A 63-year-old male with no previous history of trauma had an...

  • A comparison of the performance of Ga-DOTATATE PET/CT and I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Maurice, J.; Troke, R.; Win, Z.; Ramachandran, R.; Al-Nahhas, A.; Naji, M.; Dhillo, W.; Meeran, K.; Goldstone, A.; Martin, N.; Todd, J.; Palazzo, F.; Tan, T. // European Journal of Nuclear Medicine & Molecular Imaging;Aug2012, Vol. 39 Issue 8, p1266 

    Purpose: To compare the sensitivity of I-metaiodobenzylguanidine (MIBG) SPECT and Ga-DOTATATE PET/CT in detecting phaeochromocytomas (PCC) and paragangliomas (PGL) in the initial diagnosis and follow-up of patients with PCC and PGL disease. Methods: Retrospective analysis of 15 patients with...

  • Comparison of 18F-fluoride PET/CT, 18F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study. NAOTOSHI OTA; KATSUHIKO KATO; SHINGO IWANO; SHINJI ITO; SHINJI ABE; NAOTOSHI FUJITA; KEIICHI YAMASHIRO; SEIICHI YAMAMOTO; SHINJI NAGANAWA // British Journal of Radiology;Feb2014, Vol. 87 Issue 1034, p1 

    Objective: We compared the efficacies of 18F-fluoride positron emission tomography (18F-fluoride PET)/CT, 18F-fludeoxyglucose PET (18F-FDG PET)/CT, and 99mTc bone scintigraphy [planar and single photon emission CT (SPECT)] for the detection of bone metastases in patients with differentiated...

  • Functional imaging in phaeochromocytoma and neuroblastoma with Ga-DOTA-Tyr-octreotide positron emission tomography and I-metaiodobenzylguanidine. Kroiss, Alexander; Putzer, Daniel; Uprimny, Christian; Decristoforo, Clemens; Gabriel, Michael; Santner, Wolfram; Kranewitter, Christof; Warwitz, Boris; Waitz, Dietmar; Kendler, Dorota; Virgolini, Irene Johanna // European Journal of Nuclear Medicine & Molecular Imaging;May2011, Vol. 38 Issue 5, p865 

    Purpose: Ga-DOTA-Tyr-octreotide positron emission tomography (Ga-DOTA-TOC PET) has proven to be superior to In-DTPA-D-Phe-octreotide (In-octreotide) planar scintigraphy and SPECT imaging in neuroendocrine tumours (NETs). Because of these promising results, we compared the accuracy of...

  • Iodine-131MIBG SPECT/CT in neuroendocrine tumours: An institutional experience. Verma, Priyanka; Chanadana; Hephzibah, Julie; Shanthly, Nylla; Oommen, Regi // Indian Journal of Nuclear Medicine;Oct2012, Vol. 27 Issue 4, p246 

    Context: Radiolabelled metaiodobenzylguanidine (MIBG) is commonly used for imaging of neuroendocrine tumors (NETs). The hybrid imaging with single photon emission computerized tomography/computerized tomography (SPECT/CT) co-registration can give that additional edge to this functional imaging...

  • Nuclear medicine imaging of neuroendocrine tumours. Al-Nahhas, Adil // Clinical Medicine;Aug2012, Vol. 12 Issue 4, p377 

    The article discusses nuclear medicine imaging of neuroendocrine tumours (NETs), a clinically diverse group of tumours which commonly affect the gastroenteropancreatic tract and lungs. NETs comprise carcinoid tumours and various pancreatic tumours such as gastrinoma, insulinoma, VIPoma,...

  • SPECT/CT and tumour imaging. Abikhzer, Gad; Keidar, Zohar // European Journal of Nuclear Medicine & Molecular Imaging;May2014 Supplement, Vol. 41, p67 

    Scintigraphic techniques are sensitive imaging modalities in the diagnosis and follow-up of cancer patients providing the functional and metabolic activity characteristics of the tumour. Hybrid SPECT/CT improves the diagnostic accuracy of these well-established imaging techniques by precise...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics